Well as far as the clinical trial comments you might want to reread my post and focus on and understand the following statement.
What I stated about the clinical trials made no sense to me and I seriously doubt any of it is accurate. That was the entire point.
Now if you want to call my LPC comments “hogwash” well that’s a horse of a different color.
It’s a fact (indisputable imho) about the first 6.7 million shares they used up to improve the cash position in the last fiscal year. The fate of the newly authorized 5 million shares is indeed only a theory. I stated that clearly I believe.
I don’t own any stock. That’s why I’m not reluctant to state the facts as I see them both positive and negative.
My motivations are my motivations and are simply not based on a long or short position in this stock, as hard as that might be to understand that’s the facts of that matter.
Hope you make a lot of money on this investment because it will mean patients suffering with CNS diseases are the beneficiaries as well.